Hindun Wilda Risni
PhD in School of Pharmacy, University College London
Topik Penelitian: Pharmacoepidemiology: cardiovascular outcome in hormone therapy
Afiliasi: Universitas Indonesia
Bidang Keilmuan: Life Sciences and Medicine
Kontribusi
Publikasi
- Aviatin, M., Sauriasari, R., Yunir, E., & Risni, H. W. (2023). Evaluation of the Use of Antimicrobial Therapy for Treating Diabetic Foot Infections in an Indonesia Referral Hospital: A Retrospective Cohort Study. Infection & Chemotherapy, 55(1), 80. https://doi.org/10.3947/ic.2022.0084
- Pratama, V., Risni, H. W., Yunir, E., & Sauriasari, R. (2022). A Systematic Review of Randomized Controlled Trials of Antibiotic Use in Diabetic Foot Ulcer Infections: Focus on Clinical Cure. Infection & Chemotherapy, 54(1), 125. https://doi.org/10.3947/ic.2021.0144
- Risni, H. W., Sauriasari, R., & Satifa, O. (2022). Tolvaptan response predictors in acute heart failure patients with congestion. Pharmaceutical Sciences Asia, 49(1), 98–105. https://doi.org/10.29090/psa.2022.01.21.119
- Damayanti, H., Sajinadiyasa, I. G. K., Risni, H. W., & Sauriasari, R. (2021). The Effectiveness and Safety of Favipiravir in COVID-19 Hospitalized Patients at Tertiary Referral Hospital, Bali, Indonesia. Kesmas: National Public Health Journal, 16(4). https://doi.org/10.21109/kesmas.v16i4.5433
- Rachman, A., Sauriasari, R., Syafhan, N. F., Prawiroharjo, P., & Risni, H. W. (2022). Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea. Kesmas: Jurnal Kesehatan Masyarakat Nasional, 17(4), 270. https://doi.org/10.21109/kesmas.v17i4.6303